MYELOID TARGETING PLATFORM
LIVE

Serial Number

98086316

Owner

UNITED IMMUNITY, CO., LTD.

Attorney

Boris Umansky

First Use Date

Jun 3, 2024

Filing Date

Jul 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MYELOID TARGETING PLATFORM Trademark

Serial Number: 98086316 • Registration: 7591913

MYELOID TARGETING PLATFORM is a trademark filed by UNITED IMMUNITY, CO., LTD. on July 14, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

UNITED IMMUNITY, CO., LTD.

1-12-3, Nihonbashi-Muromachi, Chuo-ku
Tokyo 103-0022 , JP

Entity Type: 03

Trademark Details

Filing Date

July 14, 2023

Registration Date

December 3, 2024

First Use Anywhere

June 3, 2024

First Use in Commerce

June 3, 2024

Goods & Services

Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical research services in the field of cancer; scientific research; medical research; medical and scientific research in the field of drug discovery; pharmaceutical research services; medical and scientific research information in the field of drug discovery; DNA screening for scientific research purposes; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; cell culture services for scientific and research purposes, for others; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; DNA analysis services for scientific research purposes; scientific research consulting

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Dec 3, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Nov 12, 2024 CNTA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2024 CNEA
USE AMENDMENT ACCEPTED
Oct 11, 2024 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2024 CRFA
ASSIGNED TO LIE
Oct 9, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2024 TROA
AMENDMENT TO USE PROCESSING COMPLETE
Jun 24, 2024 AUPC
USE AMENDMENT FILED
Jun 24, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jun 24, 2024 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2023 NWOS
NEW APPLICATION ENTERED
Jul 18, 2023 NWAP